These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 4374953

  • 1. Inhibition of various cyclic AMP phosphodiesterases by pentifylline and theophylline.
    Stefanovich V, von Pölnitz M, Reiser M.
    Arzneimittelforschung; 1974 Nov; 24(11):1747-51. PubMed ID: 4374953
    [No Abstract] [Full Text] [Related]

  • 2. Concerning specificity of the influence of pentoxifylline on various cyclic AMP phosphodiesterases.
    Stefanovich V.
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):673-80. PubMed ID: 4370974
    [No Abstract] [Full Text] [Related]

  • 3. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
    McNeill JH, Brenner MJ, Muschek LD.
    Recent Adv Stud Cardiac Struct Metab; 1973 Aug; 3():261-73. PubMed ID: 4377599
    [No Abstract] [Full Text] [Related]

  • 4. Phosphodiesterase inhibition as a mechanism for the diuretic activity of 1 ((tert-butylimino)methyl)-2-(3-indolyl)indoline hydrochloride (MJ-8592-1).
    Amer MS, Gomoll AW, McKinney GR.
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):467-76. PubMed ID: 4342315
    [No Abstract] [Full Text] [Related]

  • 5. The inhibition of c-AMP-phosphodiesterase by phenobarbitone.
    Pansegrouw D.
    S Afr Med J; 1975 Mar 01; 49(9):317-8. PubMed ID: 163503
    [Abstract] [Full Text] [Related]

  • 6. Inhibition and enhancement of the noradrenaline constrictor response by methylxanthines.
    McNeill JH, Hook JB, Davis RS.
    Can J Physiol Pharmacol; 1973 Jul 01; 51(7):553-5. PubMed ID: 4354258
    [No Abstract] [Full Text] [Related]

  • 7. Increase of hepatic L-phenylalanine: pyruvate aminotransferase by glucagon in rats. Possible role of adenosine cyclic 3',5'-monophosphate as a mediator.
    Fuller RW, Snoddy HD, Bromer WW.
    Mol Pharmacol; 1972 May 01; 8(3):345-52. PubMed ID: 4339289
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of 3',5'-cyclic AMP phosphodiesterase with anti-inflammatory agents.
    Stefanovich V.
    Res Commun Chem Pathol Pharmacol; 1974 Mar 01; 7(3):573-82. PubMed ID: 4363357
    [No Abstract] [Full Text] [Related]

  • 13. Assay of phosphodiesterase with radioactively labeled cyclic 3',5'-AMP as substrate.
    Pöch G.
    Naunyn Schmiedebergs Arch Pharmakol; 1971 Mar 01; 268(3):272-99. PubMed ID: 4337726
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analogs of alpha-tocopherol as inhibitors of cyclic-AMP and cyclic-GMP phosphodiesterases and effects of alpha-tocopherol deficiency on cyclic AMP-controlled metabolism.
    Schroeder J.
    Biochim Biophys Acta; 1974 Mar 20; 343(1):173-81. PubMed ID: 4364126
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.